Immune checkpoint blockade in renal cell carcinoma

Immune checkpoint blockade in renal cell carcinoma

Show other versions (2)
Saved in:
Bibliographic Details
Other Authors: McDermott, David (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2016.
Series:Henry Stewart talks. Biomedical & life sciences collection. Immunotherapy of cancer.
Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease.
Subjects:
Antineoplastic agents.
Cancer > Immunological aspects.
Immunotherapy.
Kidneys > Cancer > Chemotherapy.
Kidneys > Cancer > Immunological aspects.
Renal cell carcinoma.
Antibodies, Monoclonal > therapeutic use.
Antineoplastic Agents > therapeutic use.
Carcinoma, Renal Cell > drug therapy.
Carcinoma, Renal Cell > immunology.
Cell Cycle Checkpoints.
Clinical Trials as Topic.
Combined Modality Therapy.
CTLA-4 Antigen > immunology.
Immunotherapy > methods.
Kidney Neoplasms > drug therapy.
Kidney Neoplasms > immunology.
Patient Selection.
Programmed Cell Death 1 Receptor > antagonists & inhibitors.
T-Lymphocytes > immunology.
Online Access:https://hstalks.com/bs/3242/
Series (Immunotherapy of cancer)
Series (Kidney in health and disease)
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000ngm a2200000 a 4500
001 HST4211
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 160414s2016 enk|||||||||||s|||v|eng d
028 5 0 |a 4211  |b Henry Stewart Talks 
035 |a (UkLoHST)3242 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a McDermott, David,  |u (Harvard Medical School, USA)  |4 spk 
245 1 0 |a Immune checkpoint blockade in renal cell carcinoma  |h [electronic resource] /  |c David McDermott. 
260 |a London :  |b Henry Stewart Talks,  |c 2016. 
300 |a 1 online resource (1 streaming video file (58 min.) :  |b color, sound). 
490 1 |a Immunotherapy of cancer,  |x 2056-452X 
490 1 |a The kidney in health and disease,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
505 0 |a Contents: Recent data that has led to the approval of PD-1 blockade in RCC -- Approaches to patient selection -- Novel combination therapies that are entering pivotal trials. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Antineoplastic agents. 
650 0 |a Cancer  |x Immunological aspects. 
650 0 |a Immunotherapy. 
650 0 |a Kidneys  |x Cancer  |x Chemotherapy. 
650 0 |a Kidneys  |x Cancer  |x Immunological aspects. 
650 0 |a Renal cell carcinoma. 
650 2 |a Antibodies, Monoclonal  |x therapeutic use. 
650 2 |a Antineoplastic Agents  |x therapeutic use. 
650 2 |a Carcinoma, Renal Cell  |x drug therapy. 
650 2 |a Carcinoma, Renal Cell  |x immunology. 
650 2 |a Cell Cycle Checkpoints. 
650 2 |a Clinical Trials as Topic. 
650 2 |a Combined Modality Therapy. 
650 2 |a CTLA-4 Antigen  |x immunology. 
650 2 |a Immunotherapy  |x methods. 
650 2 |a Kidney Neoplasms  |x drug therapy. 
650 2 |a Kidney Neoplasms  |x immunology. 
650 2 |a Patient Selection. 
650 2 |a Programmed Cell Death 1 Receptor  |x antagonists & inhibitors. 
650 2 |a T-Lymphocytes  |x immunology. 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Immunotherapy of cancer. 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Kidney in health and disease. 
856 4 0 |u https://hstalks.com/bs/3242/ 
856 4 2 |u https://hstalks.com/bs/p/896/  |3 Series (Immunotherapy of cancer) 
856 4 2 |u https://hstalks.com/bs/p/980/  |3 Series (Kidney in health and disease) 
999 |c 200912  |d 200912 

Similar Items